Literature DB >> 8512347

Maternal serum CA125 levels in early intrauterine and tubal pregnancies.

F Kobayashi1, E Takashima, N Sagawa, T Mori, S Fujii.   

Abstract

Using an immunoradiometric assay, serum CA125 levels were measured in 13 women with a normal pregnancy, 9 with a spontaneous abortion, 3 with a hydatidiform mole, and 15 with a tubal pregnancy. Serum CA125 levels were high in patients with a normal pregnancy (154 +/- 169 U/ml; mean +/- S.D.), a spontaneous abortion (244 +/- 258 U/ml), or a hydatidiform mole (54 +/- 16 U/ml). In contrast, CA125 levels in patients with a tubal pregnancy (33 +/- 25 U/ml) were low, and almost all of those without uterine bleeding (25 +/- 9 U/ml) were within the normal range for non-pregnant women (< 35 U/ml). The difference between serum CA125 levels with intrauterine pregnancy and with tubal pregnancy may be ascribed to the difference of the amount of decidual tissues at the site of trophoblastic invasion.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512347     DOI: 10.1007/BF02426356

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  14 in total

1.  CA 125 levels in abruptio placentae.

Authors:  B R Witt; R Miles; G C Wolf; G T Koulianos; I H Thorneycroft
Journal:  Am J Obstet Gynecol       Date:  1991-05       Impact factor: 8.661

2.  Relaxin, CA-125, progesterone, estradiol, Schwangerschaft protein, and human chorionic gonadotropin as predictors of outcome in threatened and nonthreatened pregnancies.

Authors:  B R Witt; G C Wolf; C J Wainwright; P D Johnston; I H Thorneycroft
Journal:  Fertil Steril       Date:  1990-06       Impact factor: 7.329

3.  Immunohistochemical localization and tissue levels of tumor-associated glycoproteins CA 125 and CA 19-9 in the decidua and fetal membranes at various gestational ages.

Authors:  F Kobayashi; N Sagawa; Y Nanbu; K Nakamura; M Nonogaki; C Ban; S Fujii; T Mori
Journal:  Am J Obstet Gynecol       Date:  1989-05       Impact factor: 8.661

4.  CA 125 in tissues and amniotic fluid during pregnancy.

Authors:  J G Quirk; G L Brunson; C A Long; G A Bannon; M M Sanders; T J O'Brien
Journal:  Am J Obstet Gynecol       Date:  1988-09       Impact factor: 8.661

5.  Mechanism and clinical significance of elevated CA 125 levels in the sera of pregnant women.

Authors:  F Kobayashi; N Sagawa; K Nakamura; M Nonogaki; C Ban; S Fujii; T Mori
Journal:  Am J Obstet Gynecol       Date:  1989-03       Impact factor: 8.661

6.  Tissue distribution of a coelomic-epithelium-related antigen recognized by the monoclonal antibody OC125.

Authors:  S E Kabawat; R C Bast; A K Bhan; W R Welch; R C Knapp; R B Colvin
Journal:  Int J Gynecol Pathol       Date:  1983       Impact factor: 2.762

7.  CA 125 antigen in human amniotic fluid and fetal membranes.

Authors:  T J O'Brien; J W Hardin; G A Bannon; J S Norris; J G Quirk
Journal:  Am J Obstet Gynecol       Date:  1986-07       Impact factor: 8.661

8.  Serum CA 125 levels in early pregnancy and subsequent spontaneous abortion.

Authors:  J H Check; K Nowroozi; C A Winkel; T Johnson; L Seefried
Journal:  Obstet Gynecol       Date:  1990-05       Impact factor: 7.661

9.  A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Authors:  R C Bast; T L Klug; E St John; E Jenison; J M Niloff; H Lazarus; R S Berkowitz; T Leavitt; C T Griffiths; L Parker; V R Zurawski; R C Knapp
Journal:  N Engl J Med       Date:  1983-10-13       Impact factor: 91.245

10.  Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix.

Authors:  J M Niloff; T L Klug; E Schaetzl; V R Zurawski; R C Knapp; R C Bast
Journal:  Am J Obstet Gynecol       Date:  1984-04-15       Impact factor: 8.661

View more
  4 in total

1.  The Values of CA-125, Progesterone, ß-HCG and Estradiol in the Early Prediction of Ectopic Pregnancy.

Authors:  Meena M Abdul-Hussein; Omar F Abdul-Rasheed; Hala Abdul Qadir Al-Moayed
Journal:  Oman Med J       Date:  2012-03

2.  Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort.

Authors:  Renée T Fortner; Allison F Vitonis; Helena Schock; Anika Hüsing; Theron Johnson; Raina N Fichorova; Titilayo Fashemi; Hidemi S Yamamoto; Anne Tjønneland; Louise Hansen; Kim Overvad; Marie-Christine Boutron-Ruault; Marina Kvaskoff; Gianluca Severi; Heiner Boeing; Antonia Trichopoulou; Vassiliki Benetou; Carlo La Vecchia; Domenico Palli; Sabina Sieri; Rosario Tumino; Giuseppe Matullo; Amalia Mattiello; N Charlotte Onland-Moret; Petra H Peeters; Elisabete Weiderpass; Inger Torhild Gram; Mie Jareid; J Ramón Quirós; Eric J Duell; Maria-Jose Sánchez; María Dolores Chirlaque; Eva Ardanaz; Nerea Larrañaga; Björn Nodin; Jenny Brändstedt; Annika Idahl; Kay-Tee Khaw; Naomi Allen; Marc Gunter; Mattias Johansson; Laure Dossus; Melissa A Merritt; Elio Riboli; Daniel W Cramer; Rudolf Kaaks; Kathryn L Terry
Journal:  J Ovarian Res       Date:  2017-03-20       Impact factor: 4.234

Review 3.  Serum markers in the diagnosis of tubal pregnancy.

Authors:  Fabio Roberto Cabar; Paula Beatriz Fettback; Pedro Paulo Pereira; Marcelo Zugaib
Journal:  Clinics (Sao Paulo)       Date:  2008-10       Impact factor: 2.365

4.  The ratio of cervical fluid and serum human chorionic gonadotropin as a predictor of abortion.

Authors:  Shahrzad Zadehmodares; Nafiseh Baheiraei; Afsar Sharafi; Mehdi Hedayati; Mansoureh Mousavi
Journal:  Iran J Reprod Med       Date:  2012-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.